Every article, report, and earnings note where ENSG appears.
3 articles
The short-report hit on Ensign is serious, but the selloff is running into a business that just posted record occupancy, 21.7% adjusted EPS growth, and higher full-year guidance. We see this as a test of whether allegations can overpower a long-running execution story, and right now execution still has the better numbers.
Ensign is turning skilled nursing into a repeatable growth machine, with double-digit revenue and EPS growth, record occupancy, and a balance sheet that still supports acquisitions. The stock looks like a quality compounder, but valuation keeps the stance at Buy on pullbacks.
The Ensign Group, Inc. (ENSG) falls sharply after a short-seller report accused the healthcare operator of staffing and care-quality issues. The stock’s 10.9% drop on heavy volume reflects a sudden loss of confidence, even as recent earnings and guidance had been strong.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate ENSG Report